Download FREE Report Sample
Download Free sampleCitalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
Citalopram Market contains market size and forecasts of Citalopram in Global, including the following market information:
Global Citalopram Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Citalopram market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Citalopram include H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals and Jubilant Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Citalopram companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Citalopram Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Citalopram Market Segment Percentages, by Type, 2021 (%)
Solution
Tablets
Other
Global Citalopram Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Citalopram Market Segment Percentages, by Application, 2021 (%)
Depression
Generalized Anxiety
Obsessive Compulsive Disorder
Somatoform Disorder
Schizophrenia
Other
Global Citalopram Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Citalopram Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Citalopram revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Citalopram revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
H.Lundbeck A/S
Amneal Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Apotex
Hikma Pharmaceuticals
Jubilant Pharma
Lupin Limited
Prinston Pharmaceutical
STI Pharma
TEVA Pharmaceutical
Hexal
Shanghai Great Wall Pharmaceutical
Wanquan Wante Pharmaceutical
Northeast Pharmaceutical Group
Sichuan Kelun Pharmaceutical
Kunming Jida Pharmaceutical
Jiangsu Enhua Pharmaceutical
Southwest Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
